9 compounds
Incretin analogues.
GLP-1, GIP, glucagon and amylin receptor agonists for metabolic research.
Incretin-pathway peptides are synthetic analogues of hormones released by the gut after a meal — GLP-1, GIP, glucagon and amylin. In published research they act on their matching G-protein-coupled receptors to study insulin secretion, gastric emptying and energy-intake signalling in cell and animal models. The catalogue includes single-agonist and dual-agonist analogues used as reference standards in receptor-binding and metabolic-pathway assays.
